Bernet V - Search Results

1

Approach to the patient with incidental papillary microcarcinoma.

Bernet V. Bernet V. J Clin Endocrinol Metab. 2010 Aug;95(8):3586-92. doi: 10.1210/jc.2010-0698. J Clin Endocrinol Metab. 2010. PMID: 20685885

2

An uncommon cause of asymptomatic primary hyperparathyroidism.

Abate EG, Bernet V, May GR, Smallridge RC. Abate EG, et al. Among authors: bernet v. J Clin Endocrinol Metab. 2012 Dec;97(12):4304-5. doi: 10.1210/jc.2012-2419. Epub 2012 Sep 19. J Clin Endocrinol Metab. 2012. PMID: 22993031 No abstract available.

3

Surgical considerations for papillary thyroid microcarcinomas.

Boucai L, Bernet V, Shaha A, Shindo ML, Stack BC, Tuttle RM. Boucai L, et al. Among authors: bernet v. J Surg Oncol. 2017 Sep;116(3):269-274. doi: 10.1002/jso.24673. Epub 2017 May 17. J Surg Oncol. 2017. PMID: 28513849 Review.

4

An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.

McIver B, Castro MR, Morris JC, Bernet V, Smallridge R, Henry M, Kosok L, Reddi H. McIver B, et al. Among authors: bernet v. J Clin Endocrinol Metab. 2014 Nov;99(11):4069-77. doi: 10.1210/jc.2013-3584. Epub 2014 Apr 29. J Clin Endocrinol Metab. 2014. PMID: 24780044

5

Visual vignette. Type 1A pseudohypoparathyroidism.

Ally MR, Bernet VJ, Atwood JE. Ally MR, et al. Endocr Pract. 2008 Oct;14(7):952. doi: 10.4158/EP.14.7.952. Endocr Pract. 2008. PMID: 18996830 No abstract available.

6

Bilateral external laryngoceles following radioiodine ablation for Graves disease.

Stocker DJ, Kelly WF, Fitzpatrick TM, Bernet VJ, Burch HB. Stocker DJ, et al. Arch Intern Med. 2002 Sep 23;162(17):2007-9. doi: 10.1001/archinte.162.17.2007. Arch Intern Med. 2002. PMID: 12230425

7

Reversible renal insufficiency attributable to thyroid hormone withdrawal in a patient with type 2 diabetes mellitus.

Bernet VJ. Bernet VJ. Endocr Pract. 2004 Jul-Aug;10(4):339-44. doi: 10.4158/EP.10.4.339. Endocr Pract. 2004. PMID: 15760778

8

Clinical and molecular features of Hürthle cell carcinoma of the thyroid.

Chindris AM, Casler JD, Bernet VJ, Rivera M, Thomas C, Kachergus JM, Necela BM, Hay ID, Westphal SA, Grant CS, Thompson GB, Schlinkert RT, Thompson EA, Smallridge RC. Chindris AM, et al. J Clin Endocrinol Metab. 2015 Jan;100(1):55-62. doi: 10.1210/jc.2014-1634. J Clin Endocrinol Metab. 2015. PMID: 25259908

9

Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells.

Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F, Burman KD, Saji M. Ringel MD, et al. J Clin Endocrinol Metab. 2002 May;87(5):2399. doi: 10.1210/jcem.87.5.8626. J Clin Endocrinol Metab. 2002. PMID: 11994395

10

Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.

Bernet VJ, Anderson J, Vaishnav Y, Solomon B, Adair CF, Saji M, Burman KD, Burch HB, Ringel MD. Bernet VJ, et al. J Clin Endocrinol Metab. 2002 Oct;87(10):4792-6. doi: 10.1210/jc.2002-020390. J Clin Endocrinol Metab. 2002. PMID: 12364475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results